About the Authors

Kasmintan A. Schrader

Contributed equally to this work with: Kasmintan A. Schrader, Bella Gorbatcheva

Affiliations Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

Bella Gorbatcheva

Contributed equally to this work with: Kasmintan A. Schrader, Bella Gorbatcheva

Affiliation Novartis Institute for Biomedical Research, Cambridge, Massachusetts, United States of America

Janine Senz

Affiliations Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

Alireza Heravi-Moussavi

Affiliation Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada

Nataliya Melnyk

Affiliations Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

Clara Salamanca

Affiliation Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada

Sarah Maines-Bandiera

Affiliation Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada

Susanna L. Cooke

Affiliation Cancer Research, Cambridge Research Institute, Cambridge, United Kingdom

Peter Leung

Affiliation Department of Obstetrics and Gynecology, University of British Columbia, Child and Family Research Institute, Vancouver, British Columbia, Canada

James D. Brenton

Affiliation Cancer Research, Cambridge Research Institute, Cambridge, United Kingdom

C. Blake Gilks

Affiliation Genetic Pathology and Evaluation Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada

John Monahan

Affiliation Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada

David G. Huntsman

dhuntsma@bccancer.bc.ca

Affiliations Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada, Novartis Institute for Biomedical Research, Cambridge, Massachusetts, United States of America, Genetic Pathology and Evaluation Centre, Vancouver General Hospital, Vancouver, British Columbia, Canada

Competing Interests

The British Columbia Cancer Agency is the holder of a provisional patent on the use of the FOXL2 mutation as a potential diagnostic and therapeutic target. Bella Gorbatcheva and John Monahan are both employees of the Novartis Institutes for BioMedical Research. These competing interests do not impact the sharing of data related to this publication.

Author Contributions

Conceived and designed the experiments: KAS BG JDB CBG JM DH. Performed the experiments: BG JS AHM NM CS SMB SLC JM. Analyzed the data: KAS BG JS AHM NM PL JDB CBG JM DH. Contributed reagents/materials/analysis tools: CS SMB SLC PL JDB CBG JM. Wrote the paper: KAS BG JDB JM DH.